Detection and inactivation of porcine parvovirus in pharmaceutical ingredients

药物成分中猪细小病毒的检测和灭活

• 批准号: 335018-2005
• 负责人: Tijssen, Peter
• 金额: $ 5.28万
• 依托单位: Institut national de la recherche scientifique
• 依托单位国家: 加拿大
• 项目类别: Collaborative Research and Development Grants
• 财政年份: 2008
• 资助国家: 加拿大
• 起止时间: 2008-01-01 至 2009-12-31
• 项目状态: 已结题
• 来源: https://www.nserc-crsng.gc.ca/ase-oro/Details-Detailles_eng.asp?id=398911
• 关键词: Detection; inactivation; porcine; parvovirus; pharmaceutical

To this date, many pharmaceutical products are manufactured from biological sources. When the products are derived from animal sources, it is essential to ensure the safety of the product by demonstrating the absence of viral contaminants.

到目前为止，许多药物产品都是从生物来源生产的。当产品来源于动物源时，必须通过证明不存在病毒污染物来确保产品的安全性。